Renflexis

Renflexis In Modesto, CA

Renflexis (infliximab-abda) is a biosimilar of Remicade. Renflexis is indicated for the treatment of Crohn’s Disease, pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis. Inflectra is administered as an intravenous infusion.

Administration Information

A biosimilar is a medicine approved by the Food and Drug Administration (FDA) as being highly similar to an already approved biologic medicine. The FDA refers to the already approved biologic as the reference product. It is also known as the originator or original biologic product.

Potential Side Effects

RENFLEXIS treats the same autoimmune diseases as Remicade. It works the same way, has the same dosage and is taken the same way. This means you can expect similar safety and effectiveness from the biosimilar over the course of treatment as you would from the reference product.

Conditions Treated

Helpful Resources

The Omega Health Clinics Experience

We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.

At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.

Contact our Providers

209-554-4181

Get In Touch